Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite ...

The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...

Boltz-2 is the latest milestone in MIT Jameel Clinic’s growing portfolio of open-source tools for health, developed at the ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

Addressing protein aggregation, product stability, supply chains, and regulations requires multiple tools, including ...

Antibody-drug conjugates (ADCs) hit the scene in oncology many moons ago – in fact, this year marks 25 years since the first ...

Regulatory science also plays a crucial role in ensuring public trust in these products and facilitating the translation of ...

That challenge, of finding or building good, usable data sets, is also one of the biggest differentiators in an increasingly ...

Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are ...

ZS’s India hub is reshaping global healthcare by pioneering AI and GenAI applications in drug discovery, clinical trials, and ...

This episode of Chromatography Life takes a closer look at synthetic peptide drugs - one of the most compelling frontiers in biopharmaceutical analysis.